Results 111 to 120 of about 1,498,446 (168)
An Underrecognized Problem: Missed and Delayed Carbidopa-Levodopa Administration in Emergency Department Patients With Parkinson's Disease. [PDF]
Acad Emerg MedElder NM, Lash EM, Tomkins-Tinch C.
europepmc +1 more source
Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson's disease. [PDF]
BMC NeurolSaidvaliyev F +10 more
europepmc +1 more source
Four New Pairs of MetO-Containing Diketopiperazine Enantiomers: Isolation, Synthesis and Potential Anti-Parkinson's Disease Activity. [PDF]
Mar DrugsLei Y +6 more
europepmc +1 more source
Long-Duration Response to Levodopa in the PPMI-Cohort. [PDF]
Mov DisordSchnalke N +3 more
europepmc +1 more source
[Abuse of the antiparkinson agents biperidin and benzhexol].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983 openaire +1 more source
[Neuromuscular disorders due to adverse effects of antiparkinson agents].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Carotenoids as Antiparkinson Agents
2021Parkinson’s disease (PD) is a neurodegenerative disease associated with the loss of dopaminergic neurons in the portions of the brain via multiple pathological mechanisms. Despite the fact that enormous progress occurred in the cure of Parkinson’s disorder, but the incidence and risk of this disease is increasing alarmingly over the past few decades ...
Saikat Dewanjee +2 more
exaly +2 more sources
Reactions to Antiparkinson Agents
1987The cardiovascular effects are dose-related. Low doses can cause transient bradycardia; moderate or high doses can cause tachycardia, palpitation, and arrhythmias (due to blockage of vagal effects on the S-A node).
Frank L. Tornatore +3 more
exaly +2 more sources